Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.44 USD | -5.68% | -25.43% | -51.82% |
Sales 2024 * | 14.8M 1.23B | Sales 2025 * | 19.28M 1.61B | Capitalization | 3.96M 330M |
---|---|---|---|---|---|
Net income 2024 * | -3M -250M | Net income 2025 * | - 0 | EV / Sales 2024 * | 0.27 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.21 x |
P/E ratio 2024 * |
-0.36
x | P/E ratio 2025 * |
3.93
x | Employees | 25 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.97% |
Latest transcript on NovaBay Pharmaceuticals
1 day | -5.68% | ||
1 week | -25.43% | ||
1 month | +21.64% | ||
3 months | -32.73% | ||
6 months | -67.27% | ||
Current year | -51.82% |
Managers | Title | Age | Since |
---|---|---|---|
Justin Hall
CEO | Chief Executive Officer | 46 | 01/13/01 |
Tommy Law
DFI | Director of Finance/CFO | 38 | 01/19/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Freiman
CHM | Chairman | 89 | 01/02/01 |
Yen You Zheng
BRD | Director/Board Member | 67 | 11/19/11 |
Bob Wu
BRD | Director/Board Member | 49 | 26/16/26 |
Date | Price | Change | Volume |
---|---|---|---|
31/24/31 | 3.44 | -5.68% | 313,764 |
30/24/30 | 3.647 | -36.11% | 572,721 |
29/24/29 | 5.708 | +15.67% | 1,408,562 |
28/24/28 | 4.935 | +6.98% | 267,863 |
24/24/24 | 4.613 | -5.86% | 279,104 |
Delayed Quote Nyse, May 01, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-51.82% | 3.76M | |
+43.36% | 58.06B | |
-5.31% | 40.53B | |
+37.52% | 38.99B | |
+14.75% | 26.7B | |
-12.56% | 26.56B | |
-22.45% | 18.98B | |
+0.04% | 12.17B | |
+25.12% | 12B | |
+26.04% | 11.92B |
- Stock Market
- Equities
- NBY Stock